Allurion is preparing to enter the US market with a non-surgical weight loss device ... and here we’re talking about one milligram of semaglutide weekly, which is, half of what you would ...

Weight loss treatment combining personalized semaglutide with intensive behavioral therapy (IBT) yields weight loss similar to that reported in confirmatory trials, with a lower dose of medication.

A study, which was published in The New England Journal of Medicine, found that tirzepatide (Zepbound) is more effective for ...

Scientists found brain cells behind semaglutide’s weight-loss power—and they don’t cause the nasty side effects.

By pairing semaglutide with one or two experimental antibodies designed to preserve muscle, participants lost less lean body ...

A study of real-world and virtual patients suggests that a less frequent dosing of glucagon-like peptide 1 receptor agonists ...

Regeneron’s trial shows semaglutide combos improve fat loss while preserving muscle in obesity treatment. Read more here.

For patients with a body mass index (BMI) of 70 or higher, metabolic surgery is a highly effective treatment for this form of ...

At the least, the new 7.2mg results point to scope for hiking the semaglutide dose in CagriSema to chase down that weight-loss target. The company is also running a phase 3b trial of 7.2mg ...

Regeneron highlighted that about 35% of weight loss from semaglutide alone was due to lean mass loss, which combo therapies ...

While surgical weight loss can involve significant upfront costs, it may be more cost-effective over time compared to the long-term expenses associated with managing obesity-related health conditions.